Skip to main content
Clinical Trials/ChiCTR2600118708
ChiCTR2600118708CompletedUnknown

Effectiveness of Inspiratory Muscle Training on Dyspnea and Fatigue among Critically-Ill Burn Patients Receiving High-Flow Nasal Oxygen Therapy: A Randomized Controlled Trial

Self-financed1 site in 1 country56 target enrollmentStarted: November 10, 2025Last updated:

Trial Snapshot

Phase
Unknown
Status
Completed
Sponsor
Enrollment
56
Locations
1
Primary Endpoint
Dyspnea

Study Overview

Brief Summary

  1. To evaluate the effectiveness of inspiratory muscle training on dyspnea among critically ill burn patients receiving high-flow nasal oxygen therapy (pre-post test).
  2. To evaluate the effectiveness of inspiratory muscle training on fatigue among critically ill burn patients receiving high-flow nasal oxygen therapy (pre-post test).
  3. To find out the relationship between effectiveness inspiratory muscle training and patients’ sociodemographic data.

Study Design

Study Type
Interventional
Primary Purpose
随机平行对照
Masking
None

Eligibility Criteria

Ages
18 to 65 (—)
Sex
All

Inclusion Criteria

  • 1.18–65 years old adults;
  • 2.Second- or third-degree burn with >=20% TBSA;
  • 3.Stable and cooperative;
  • 4.Under high-flow nasal oxygen therapy (HFNC);
  • 5.Maximum Inspiratory Pressure (MIP) Ranges between 9 and 41 cmH2O.

Exclusion Criteria

  • 1.Unstable chronic cardiovascular or respiratory diseases.
  • 2.Present acute respiratory infections.
  • 3.Mental or physical incapability for performing IMT.
  • 4.Receipt of other therapies having an effect upon the study outcomes.
  • 5.Maximum Inspiratory Pressure (MIP) Ranges under 9_ above 41 cmH₂O.

Arms & Interventions

Control group

Conventional care

Intervention group

Conventional care and inspiratory muscle training intervention (The inspiratory muscle training protocol used in the present study was designed and implemented in accordance with evidence-based respiratory rehabilitation guidelines, including the recommendations of the American Thoracic Society and the European Respiratory Society for respiratory muscle training, as well as contemporary clinical practice guidelines for the respiratory management of critically ill and burn patients receiving high-flow nasal oxygen therapy.)

Outcomes

Primary Outcomes

Dyspnea

Time Frame: one days and fourteen days after the intervention

Fatigue

Time Frame: one days and fourteen days after the intervention

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Self-financed

Study Sites (1)

Loading locations...

Similar Trials